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transmembrane protein that transports intracellular pyrophosphate (PPi)
to the extracellular milieu. Previous studies have shown that extracellular
PPi and inorganic phosphate (Pi) resulting from PPi hydrolysis affect
cartilage mineralization as well as chondrocyte differentiation. In
addition, several lines of evidences suggest that ANK via its cytoplasmic
N-terminal and C-terminal domains interacts with other proteins and
these interactions may modulate signaling pathway activities. Since ANK
expression is low in normal healthy articular cartilage and its expression
levels increase in OA pathology, we investigated the role of ANK in OA
pathology.
Methods: Human articular chondrocytes isolated from left-over tissue
after knee replacement surgery were transfected with ank expression
vector and cultured in the absence or presence of interleukin-1 (IL-1) and
zoledronic acid, a bisphosphonate and non-hydrolysable PPi analogue.
mRNA levels of markers of articular chondrocytes (aggrecan, Sox-9. type
II collagen), hypertrophic markers (alkaline phosphatase (APase), runx2,
type X collagen), and MMP-13 were determined by real time PCR. NF-úB
activity was determined by transfection of human chondrocytes with
a NF-úB-speciﬁc luciferase reporter plasmid. Mineralization of human
chondrocytes in the absence or presence of PPi and levamisole (to prevent
PPi hydrolysis) was determined using alizarin red S staining. Finally,
femoral head explants isolated from ank/ank mice, which lack functional
ANK, and wild type littermates were cultured in the absence or presence
of IL-1.
Results: Overexpression of ANK in human chondrocytes resulted in
decreased mRNA levels of articular cartilage markers and increased
mRNA levels of hypertrophic markers and MMP-13. Treatment of
human chondrocytes with PPi and levamisole (to prevent hydrolysis
of PPi) resulted in decreased hypertrophic differentiation and MMP-
13 expression but propagation of mineral formation. Consequently,
zoledronic acid increased aggrecan mRNA levels and decreased
hypertrophic marker and MMP-13 mRNA levels in human chondrocyte
cultures in human chondrocytes cultured in the presence or absence
of IL-1. These ﬁndings reveal that increased extracellular Pi levels
as a consequence of extracellular PPi hydrolysis are the cause for
increased hypertrophic differentiation and MMP-13 expression in ANK
expressing articular chondrocytes, whereas increased extracellular PPi
concentrations lead to calcium pyrophosphate mineral formation. ANK
overexpression in human chondrocytes also resulted in increased
luciferase activity of a NF-úB-speciﬁc luciferase reporter. In the presence
of IL-1 the increase of NF-úb activity in ANK overexpressing human
chondrocytes was even more profound than in the absence of IL-1.
The stimulatory role of ANK on NF-úB activity was a consequence of
the interaction of ANK with MYBBP1a, which prevented the shuttling
of MYBBP1a into the nucleus, where it acts as an inhibitor of NF-úB.
Finally, treatment of ank/ank femoral head explants with IL-1 resulted in
a markedly reduced loss of proteoglycans and MMP-13 immunostaining
compared with IL-1-treated wild type explants.
Conclusion: ANK via its regulatory role of PPi/Pi homeostasis and
its interaction with MYBBP1a stimulates hypertrophic differentiation,
mineralization, NF-úB activity, and MMP-13 expression in chondrocytes
during OA pathology. Interfering with ANK-mediated transport of PPi
and/or its interaction with MYBBP1a may provide novel therapeutic
strategies for the treatment of OA.
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CYTOKINES DOWNREGULATE NPP1 AND THEREFORE INDUCE
CARTILAGE MINERALIZATION IN OA
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Purpose: Calciﬁcation of cartilage is a common ﬁnding during
osteoarthritis (OA) and we have shown in a previous study that
it is directly linked to OA severity. The pyrophosphate pathway is
known to function in keeping the sensitive balance of pyrophosphate
and phosphate, thereby preventing the generation of calcium crystals.
One key player in this pathway is the nucleotide pyrophosphatase
phosphodiesterase (NPP1). In the present study we analysed the
expression of NPP1 in OA cartilage and its effects on changes in cartilage
biology.
Methods: We stimulated chondrocytes with IL-1 and TNFalpa and
analysed the expression of NPP1, using quantitative real time PCR
(qPCR). In 120 consecuitve OA patients, we isolate RNA and assessed the
expression of NPP1, ANK and TNAP by qPCR. We analysed the expression
of NPP1 in induced OA in C57/bl6 mice, as well as in cartilage samples of
OA patients by immunhistochemical stainings.The mouse that carrying
a mutation in the enpp1 gene, was used to measure the calciﬁcation
of cartilage by ﬂuorid PET-scanning and mCT. Using von Kossa in
combination with safranin orange stainings of knee sections, we assessed
the calciﬁcation of articular cartilage and menisci histologically and the
severitiy of OA using the Mankin Score of mouse and human samles.
To investigate cartilage remodelling we performed immunohistological
stainings for collagen I, collagen X, osteopontin and TRAP.
Results: Both tested cytokines downregulate the expression of NPP1.
The expression of NPP1, but not ANK and TNAP, inversely correlated
with cartilage calciﬁcation (p < 0.05) and also with the Mankin-Score.
Such inverse correlation was conﬁrmed in experimental murine OA
and was also seen on protein level. We showed that NPP1mut/mut
mice have more calciﬁcation activity than wild type controls in joints.
NPP1mut/mut mice developed typical OA-like changes as evaluated
by histological analysis as well as in vivo imaging and histological
stainings. Calciﬁcation was associated with increased expression of the
hypertrophic cartilage marker collagen X and the bone marker. We
detected osteoclasts at the interface between bone and cartilage.
Conclusions: We conclude, that NPP1 is an important player in
OA-associated cartilage calciﬁcation. Pathologic calciﬁcation in the
NPP1mut/mut mice leads to cartilage remodelling into bone.These data
suggest that OA is characterized by the re-activation of molecular
signalling cascades leading to cartilage ossiﬁcation and resemble
endochondral ossiﬁcation.
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GPR22 OVEREXPRESSION ALTERS THE COURSE OF CHONDROGENESIS
TOWARDS CHONDROCYTE HYPERTROPHY AND MATRIX
MINERALIZATION: A POSSIBLE LINK TO OSTEOARTHRITIS ?
F. Cailotto, R.J. Lories. Katholieke Univ.it Leuven, Leuven, Belgium
Purpose: Osteoarthritis (OA) is a highly disabling pathology of the bone-
cartilage unit, with origins being both patient-dependent (weight excess,
trauma . . . ) and genetic. Recently, a locus on Chromosome 7 (7q22) was
linked to knee and hand OA by genome wide association study. In this
locus, the GPR22 gene, which codes for an orphan G-coupled receptor,
is almost absent from healthy cartilage, but strongly upregulated
in OA cartilage. As some aspects of endochondral bone formation
are recapitulated in OA (loss of stable phenotype, hypertrophy), we
investigated the inﬂuence of GPR22 during chondrogenesis.
Methods: We used the ATDC5 chondrogenic cell line. Three independent
stable clonal colonies of each, control (empty vector) and GPR22
overexpressing cells (GPR22+), were selected over 21 days (D)
using geneticin. Clones were cultured as high density micromasses
(2×105 cells/10ml) to mimic the condensation step of developing
cartilage in vivo. Chondrogenesis was induced by culturing cells
for 14D in DMEM/F12 + 5% FBS, supplemented with ITS [insulin
(10mg/ml), transferrin (10mg/ml) and sodium selenite (3 x 10–8 M)].
On D14, cells were switched to mineralization medium (aMEM +
5% FBS, supplemented with ITS) to investigate the mineralization
phase of chondrogenesis. mRNA expression of typical chondrogenesis
markers (Aggrecan (Agg), type II (Col2a1) and X (Col10a1) collagens,
Indian hedgehod (Ihh), transcription factors Sox9 and Runx2, alkaline
phosphatase (Alp) and matrix metalloproteinase (Mmp)-13) were
assessed by quantitative RT-PCR. Quantiﬁcation of Alcian Blue, Sirius red
and Alizarin red staining were used to evaluate proteoglycans, collagens
and mineralized content respectively. ERK1/2 activation, shown to be
enhanced during mineralization, was evaluated by western blot. Cell
proliferation was checked using Neutral red staining, and cell viability
was checked with Live/Dead® cell assay.
Results: During proliferation (D1–7) and hypertrophy (D11–14), Col2a1
mRNA was strongly increased in controls, but not in GPR22+. Agg mRNA
and alcian blue were less upregulated in GPR22+ than in controls. Col10a1
mRNA was detectable on D11, and strongly increased at D14 in controls,
but was signiﬁcantly higher in GPR22+. Sirius red and neutral red
intensity increased over time, and were signiﬁcantly higher in controls.
However, no difference was detected for cell viability. Sox9 mRNA was
increased at D7 in controls, while it remained unchanged in GPR22+.
Ihh and Runx2 mRNA were increased signiﬁcantly at D11 in controls,
while they were at D7 in GPR22+. Alizarin red was negative in controls,
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while being signiﬁcant at D14 in GPR22+ (prior using mineralization
medium). From D14 to D21, Runx2 mRNA remained elevated, while
Ihh was decreased, in both controls and GPR22+. MMP13, Col10a1 and
Alp mRNA were increased, and signiﬁcantly higher in GPR22+ than in
controls. Alizarin red was still more elevated in GPR22+. These data were
consistent with the enhanced activation of ERK1/2 at D14–21 in GPR22+
compared with controls.
Conclusions: Overexpression of GPR22 blocks features from the
proliferative phase of chondrogenesis, but enhances those from the
hypertrophic and mineralization phases. This underlines a critical role for
GPR22 in the fate of chondrogenic cells, and may be of interest regarding
the hypertrophic switch of articular chondrocytes in the course of OA.
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TNFR1 DEFICIENCY FACILITATES ARTICULAR CARTILAGE OSSIFICATION
AND OSTEOPHYTE FORMATION
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Purpose: Proinﬂammatory cytokines, such as IL-1 and tumor necrosis
factor a (TNFa), are suspected of causing damage to osteoarthritis (OA)
cartilage. TNFa content is elevated in the synovial ﬂuid of OA joints.
There are 2 cell surface receptors for TNFa including p55 (TNFRI) and
p75 (TNFRII). TNFa and TNFRs I and II are up-regulated in OA cartilage.
For bone metabolism, mice null for TNFR1 have signiﬁcantly increased
peak bone mass, resulting from elevated bone formation. In vitro, TNFa
inhibited mineralization of osteoblasts through regulation of NF-kB
activity. Thus, whereas TNFR1 plays roles in osteoblast differentiation,
its functions in chondrocyte metabolism is unknown. Endochondral
ossiﬁcation is an essential process for development of OA, which is
characterized by cartilage degradation and osteophyte formation. The
aim of this study is to investigate the role of TNFR1 in the maintenance
of articular tissues.
Materials and Methods: Histological evaluation of aged TNFR1−/− mice:
Knee joints of TNFR1−/− and their wild-type (WT) littermates
(52–60 weeks of age) were evaluated immunohistologicaly. Whole knee
joints were removed by dissection, ﬁxed in 4% paraformaldehyde, and
decalciﬁed in EDTA. After dehydration and parafﬁn embedding, serial
5-mm sagittal sections were made from the whole medial compartment
of the knee joint. Three sections were picked up at 100-mm intervals
from the weight-bearing region of each medial plateau of tibia, and were
stained with Safranin O-fast green and HE. Osteophyte area and articular
cartilage thickness were quantiﬁed in each slide using Image-Pro Plus
4.1 software.
Surgical induction of OA in TNFR1−/− mice: TNFR1−/− and their wild-type
(WT) littermates were surgically induced to develop OA by medial
collateral ligament transection and medial meniscectomy. Four weeks
after surgery, the mice were euthanized.
Results: At 52–60 weeks of age, whereas osteophyte formation was
detected at the medio-anterior edge of tibial plateau regardless of
genotype, osteophyte area was signiﬁcantly increased in TNFR1−/−
mice. Moreover, articular cartilage thickness was reduced at medial
end region of tibia plateau in TNFR1−/− mice, suggesting ossiﬁcation
of articular chondrocyte was advanced by TNFR1 deﬁciency. We next
compared osteoarthritis development between adult littermates of
wild-type and TNFR1−/− mice by creating a surgical osteoarthritis
model through induction of instability to the knee joints. Histological
evaluation conﬁrmed that the TNFR1 deﬁciency caused signiﬁcant
acceleration for osteophyte formation. Degree of cartilage destruction
was almost comparable between TNFR1−/− and WT. Real time PCR
analysis for epiphyseal chondrocyte from new born mice revealed mRNA
expression of type X collagen, a marker for chondrocyte hypertrophy,
was signiﬁcantly elevated in TNFR1−/− mice compared to WT littermate.
Currently, we are picking up a number of candidate genes for targets of
TNFR1 in the course of chondrocyte hypertrophy using cDNA microarray
analysis.
Conclusion: Endogenous TNFR1 had a protective effect against
osteophyte formation through inhibition of type X collagen synthesis.
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ONCOSTATIN M IN SYNOVIAL FLUID OF OSTEOARTHRITIC PATIENTS
AFFECTS CARTILAGE TURNOVER
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Purpose: Pro-and anti-inﬂammatory factors in the synovial ﬂuid play
a role in osteoarthritis (OA), although the exact pathogenesis is still
unclear. One of these factors may be oncostatin M (OSM). OSM, a pro-
inﬂammatory cytokine of the IL-6 family. OSM has been demonstrated
to play a role in cartilage degeneration, bone turnover and synovial
inﬂammation in rheumatoid arthritis, however, its role in OA remains
unclear. The current study aimed to investigate the presence of OSM in
OA synovial ﬂuid and its role in osteoarthritic cartilage degeneration.
Methods: The OSM concentration in the synovial ﬂuid (SF) of 32 OA
patients and 24 healthy donors was determined by ELISA. The presence
of receptors for OSM in osteoarthritic and healthy cartilage explants was
determined by immunohistochemistry for the OSM- and LIF-receptor.
To study the role of OSM in OA cartilage degeneration, OA cartilage
explants of 5 donors were cultured for 14 days with and without
25% OA synovial ﬂuid of multiple OA donors, and with or without
addition of a blocking antibody against OSM. To determine if the OSM
concentrations, as present in OA SF, could exert a direct effect on cartilage
metabolism, recombinant OSM was added at these concentration.
Cartilage metabolism was determined by glycosaminoglycans (GAG)
content and release.
For statistical analysis, univariate analysis of variance was performed. To
correct for inter-donor variability a randomized block design was used.
P values <0.05 were considered signiﬁcant.
Results: The concentration of OSM in SF of osteoarthritic donors ranged
from 0–570 pg/ml (average 39 pg/ml). In healthy SFs, OSM concentration
was signiﬁcantly lower, and was only detected in one donor (ﬁgure 1;
P < 0.001). Immunohistochemistry conﬁrmed the presence of both the
LIF receptor and OSM receptor in osteoarthritic cartilage and healthy
cartilage. In healthy cartilage, only the cells in the superﬁcial layer
showed positive staining for both receptors, whereas in osteoarthritic
cartilage positive cells for both receptors were found throughout the
entire depth of the cartilage. Blocking OSM in osteoarthritic SF increased
GAG content compared to cartilage explants cultured with SF alone
(ﬁgure 1; P < 0.05). Recombinant OSM alone at a concentration of 5 or
50 pg/ml did not show an effect on cartilage metabolism. Only a high
concentration of OSM (10ng/ml) could decrease GAG content (data not
shown; P < 0.05).
Conclusions:
OSM is present at increased levels in synovial ﬂuid of osteoarthritis
patients compared to synovial ﬂuid of healthy donors. Moreover,
the expressions of receptors for OSM appeared to be increased in
osteoarthritic cartilage. Blocking OSM in the synovial ﬂuid of OA patients
increases GAG content of OA cartilage explants. OSM at concentrations
present in OA SF does not affect cartilage metabolism, suggesting that
the effect is not direct, but OSM works in concert with other factors in
the synovial ﬂuid. OSM might be a target for future therapy to inhibit
cartilage degeneration in OA.
Fig. 1. Concentration of OSM in SF (*P < 0.001). Increase of GAG content
when OSM is blocked in SF (*P < 0.05).
